IV fluid shortages have recurred often enough across recent years — driven variously by hurricane-related manufacturing disruption, raw material constraints, and general market concentration among a small number of major manufacturers — that hospitals have had genuine opportunity to learn and adapt, and many have built meaningfully more resilient practices as a result.
Why IV Fluids Are Uniquely Hard to Substitute
Unlike many supply categories with viable alternative products, IV fluids have essentially no clinical substitute — a saline shortage cannot be worked around by switching to a different manufacturer's equivalent product if that manufacturer is equally affected, since the category's manufacturing concentration means a single major disruption event tends to affect the broader market rather than just one supplier.
What Hospitals Have Learned
- Fluid conservation protocols — clinical guidance on appropriate oral rehydration alternatives and more judicious IV fluid ordering practices — can meaningfully extend available supply during an active shortage without compromising patient care
- Multi-manufacturer relationships, even where day-to-day purchasing favors a primary supplier, provide genuine allocation priority advantage during a shortage compared to single-source relationships
- Concentrated electrolyte and additive stock that can be manually compounded into standard fluids offers a partial workaround when specific pre-mixed formulations become scarce
Building Standing Readiness
Facilities with the smoothest response to recent shortage events generally had pre-developed conservation protocols and clear escalation triggers ready before the shortage hit, rather than developing response plans reactively once shelves were already thinning — the same advance-planning principle that has proven valuable across nearly every supply category prone to periodic disruption.
Facilities building IV fluid supply resilience can review Healix Medical Supply's IV and vascular access catalog.
